ERCC1 and head and neck squamous cell carcinoma: The results of these investigations suggest that ERCC1 has no predictive value for or against radiochemotherapy in HNSCC on its own, but is an indicator of well-known tumor cell factors as radiosensitive cell cycle phase and normoxic condition, which influence treatment outcome.